NICOLE', Stefano
 Distribuzione geografica
Continente #
NA - Nord America 336
EU - Europa 280
AS - Asia 171
SA - Sud America 1
Totale 788
Nazione #
US - Stati Uniti d'America 334
CN - Cina 114
GB - Regno Unito 85
SG - Singapore 43
SE - Svezia 32
IT - Italia 29
FR - Francia 28
RU - Federazione Russa 28
IE - Irlanda 22
DE - Germania 21
FI - Finlandia 21
UA - Ucraina 8
KR - Corea 5
JP - Giappone 4
BE - Belgio 2
CA - Canada 2
CZ - Repubblica Ceca 2
IN - India 2
TR - Turchia 2
AZ - Azerbaigian 1
BG - Bulgaria 1
CL - Cile 1
RO - Romania 1
Totale 788
Città #
Southend 80
Chandler 79
Singapore 37
Ann Arbor 34
Woodbridge 32
Ashburn 27
Beijing 25
Jacksonville 24
Dublin 22
Helsinki 15
Shenyang 13
Lawrence 11
Princeton 11
Jinan 10
Wilmington 9
Hebei 8
Nanjing 8
Santa Clara 6
Verona 6
Seoul 5
Tianjin 5
Ningbo 4
Bologna 3
Changsha 3
Giussano 3
Haikou 3
Hangzhou 3
Houston 3
Taiyuan 3
Taizhou 3
Tokyo 3
Brno 2
Brussels 2
Clearwater 2
Fuzhou 2
Lanzhou 2
Montréal 2
Munich 2
New York 2
Baku 1
Boardman 1
Dallas 1
Düsseldorf 1
Esslingen am Neckar 1
Fairfield 1
Frankfurt am Main 1
Guangzhou 1
Jiaxing 1
Lancaster 1
London 1
Nanchang 1
Nashville 1
Redmond 1
Rieti 1
Riva 1
San Diego 1
Seattle 1
Secunderabad 1
Shenzhen 1
Sindelfingen 1
Torino 1
Villaricca 1
Washington 1
Xiangfen 1
Zhengzhou 1
Totale 540
Nome #
Successful Antifungal Combination Therapy and Surgical Approach for Aspergillus fumigatus Suppurative Thyroiditis Associated with Thyrotoxicosis and Review of Published Reports 100
Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient 92
Dolutegravir monotherapy in HIV-infected naive patients with an HIV-RNA load <100 000 copies/mL: a medium-term follow-up 86
Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV-1-infected patients 84
Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients 82
Immunovirological outcome and HIV-1 DNA decay in a small cohort of HIV-1-infected patients deintensificated from Abacavir/Lamivudine/Dolutegravir to Lamivudine plus Dolutegravir 74
Efficacy and safety of abacavir/lamivudine with raltegravir in treatment-experienced and treatment-naïve patients with HIV-1 infection: an observational, retrospective, multi-centre study 66
Raltegravir plus lamivudine as 'maintenance therapy' in suppressed HIV-1-infected patients in real-life settings 61
Darunavir/ritonavir 600/100 mg once daily: it's time for larger non-inferiority randomized trials 60
VIROLOGICAL EFFICACY OF A REDUCED DOSE OF NEVIRAPINE IN A SMALL COHORT OF SUPPRESSED HIV-1-INFECTED PATIENTS 57
Raltegravir/nevirapine dual therapy at reduced doses as 'maintenance' treatment in virally suppressed HIV-infected patients 55
Totale 817
Categoria #
all - tutte 3.103
article - articoli 3.103
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.206


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202047 0 0 0 0 0 9 4 2 1 4 11 16
2020/202185 11 14 3 15 11 7 3 0 3 9 8 1
2021/202283 7 35 1 5 0 0 1 9 2 2 2 19
2022/2023206 12 29 16 41 15 47 1 13 26 0 2 4
2023/2024104 3 9 11 10 12 20 0 13 1 6 9 10
2024/202590 9 15 9 42 12 3 0 0 0 0 0 0
Totale 817